Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
18
Synta Pharmaceuticals Corp, a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
16
U.S. health experts say about two-thirds of cancers could be prevented via lifestyle changes. The Mayo Clinic researchers explain in their Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource says maintaining proper weight by eating a healthy, low-fat diet and by stepping up moderate to vigorous physical activity to 45 to 60 minutes almost daily might reduce one- third of cancer deaths.
When the pain in her knee from an old running injury continued even after surgery, Sarah McCluan turned to the Internet for help. I don't use it to diagnose ,but I do go to the Internet for basic information," said McCluan, who downloaded some knee strengthening exercises that she is following. McCluan, 37, of Hopewell is among a growing number of wired adults searching the Internet for medical information.
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux(R) (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
Oncolytics Biotech Inc. today announced that a poster presentation covering updated results of a Phase I/II U.K. trial (REO 011) of REOLYSIN (R) combined with paclitaxel/carboplatin for patients with advanced cancers will be presented on November 17, 2009 at the 2009 AACR- NCI-EORTC Molecular Targets and Cancer Therapeutics conference being held in Boston, Massachusetts.
12
Patients with locally advanced esophageal cancer who require neoadjuvant therapy have significant dysphagia. To prospectively evaluate Polyflex stents to treat malignant dysphagia and to ameliorate weight loss in patients with locally advanced esophageal cancer who will undergo neoadjuvant therapy, scientists in the United States report.
Current study results from the report, 'A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma,' have been published. According to a study from the United Kingdom, Platinum compounds, taxanes and anthracyclines provide the major effective drug classes in the treatment of advanced and recurrent endometrial cancer and carcinosarcoma.
The development of stomach cancer is closely associated with chronic inflammation, and the Wnt/beta-catenin signaling pathway is activated in most cases of this cancer. High-mobility group A (HMGA) proteins are oncogenic chromatin factors that are primarily expressed not only in undifferentiated tissues but also in various tumors, scientists writing in the American Journal of Pathology report.
According to recent research from the United States, Radiosurgery for brain metastasis fails in some patients, who require further surgical care. In this paper the authors' goal was to evaluate prognostic factors that correlate with the survival of patients who require a resection of a brain metastasis after stereotactic radiosurgery (SRS).
A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer.
We care about your feedback. Let us know how we can improve your CancerCompass experience.